Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inpatient care for people with multiple sclerosis - a secondary data analysis in Germany between 2019 and 2024.

Neurological research and practice·2026

Same author

Multimodal imaging-based targeting approach for network-level brain stimulation.

Frontiers in neuroscience·2026

Same author

Neurological Teleconsultations in General Practice: A Stepped-Wedge Cluster Randomized Clinical Trial.

JAMA neurology·2026

Same author

Associations of the Lifestyle for Brain Health (LIBRA) index with cognitive functioning across adulthood: Variation by sex and socioeconomic status in the German National Cohort (NAKO).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

Dual-site theta stimulation modulates connectivity, but not sequence memory in older adults.

Brain communications·2026

Same author

Prevention in stroke - Current state, present gaps and probable next steps.

Neurological research and practice·2026

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Levodopa improves skilled hand functions in the elderly.

Agnes Floel¹, Peter Vomhof, Arne Lorenzen

¹Department of Neurology, University of Münster, Albert-Schweitzer-Strasse 33, 48129 Münster, Germany. floeel@uni-muenster.de

The European Journal of Neuroscience

|March 4, 2008

Summary

Levodopa supplementation improved fine motor skills in elderly individuals by enhancing the dopamine system. This suggests dopamine replenishment can aid motor function during aging.

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Related Experiment Videos

Last Updated: Jul 7, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Area of Science:

Neuroscience
Gerontology
Pharmacology

Background:

The endogenous dopamine system is crucial for motor control and learning.
Age-related decline in the nigrostriatal dopamine system can impair skilled motor function in the elderly.

Purpose of the Study:

To investigate if pharmacologically increasing dopamine levels can enhance complex motor task execution in healthy elderly individuals.
To compare the effects of levodopa with placebo on motor performance in young and elderly subjects.

Main Methods:

A double-blind, randomized, cross-over study involving 20 young and 20 elderly healthy subjects.
Subjects received either levodopa (100 mg levodopa plus 25 mg carbidopa) or placebo over three doses.
Motor function was assessed using the Jebsen-Taylor test, evaluating hand activities of daily living.

Main Results:

Levodopa significantly improved Jebsen-Taylor test performance by 4% in the elderly, particularly in fine motor tasks.
No significant improvement was observed in the young subjects.
Subjective measures like attention, fatigue, and mood remained consistent between sessions.

Conclusions:

Pharmacological augmentation of the dopaminergic system with levodopa can benefit motor function in the aging process.
This suggests a potential therapeutic strategy for age-related motor deficits by targeting dopamine pathways.